Elite in Stroke

Keith W. Muir

University Avenue, 
Glasgow, SCT, GB 
Elite in Stroke
University Avenue, 
Glasgow, SCT, GB 
OverviewLocationsClinical Research

Overview

Keith Muir practices in Glasgow, United Kingdom. Mr. Muir is rated as an Elite expert by MediFind in the treatment of Stroke. His top areas of expertise are Stroke, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Transient Ischemic Attack (TIA), Vascular Dementia, and Thrombectomy.

His clinical research consists of co-authoring 275 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 232 articles and participated in 7 clinical trials in the study of Stroke.

Gender
Male

Locations

University Avenue, Glasgow, SCT, United Kingdom
Other Locations
Western Infirmary
Glasgow, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Enrollment Status: Completed
Publish Date: September 12, 2025
Intervention Type: Drug
Study Drugs: Telmisartan, Amlodipine, Indapamide
Study Phase: Phase 3
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Antiplatelet Monotherapy
Study Phase: Phase 3
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage
Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage
Enrollment Status: Terminated
Publish Date: December 10, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS)
A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS)
Enrollment Status: Suspended
Publish Date: January 28, 2019
Intervention Type: Device
Study Phase: Not Applicable
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
Penumbra and Recanalisation Acute Computed Tomography in Ischaemic Stroke Evaluation
Penumbra and Recanalisation Acute Computed Tomography in Ischaemic Stroke Evaluation
Enrollment Status: Unknown
Publish Date: August 03, 2018
Intervention Type: Other
Study Phase: Not Applicable
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST)
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST)
Enrollment Status: Completed
Publish Date: August 03, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

275 Total Publications

Randomised, controlled Trial of CT perfusion and angiography compared to CT alone in thrombolysis-eligible acute ischaemic stroke patients: The penumbra and recanalisation acute computed tomography in ischaemic stroke evaluation (PRACTISE) trial.
Randomised, controlled Trial of CT perfusion and angiography compared to CT alone in thrombolysis-eligible acute ischaemic stroke patients: The penumbra and recanalisation acute computed tomography in ischaemic stroke evaluation (PRACTISE) trial.
Journal: European stroke journal
Published: September 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Muir's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile